---
title: (Re-) Defining "Successful Aging" as the Endpoint in Clinical Trials? Current
  Methods, Challenges, and Emerging Solutions
date: '2024-05-30'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38813871/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240530181516&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'BACKGROUND AND OBJECTIVES: "Successful aging" as defined in Rowe & Kahn''s
  model aims to include the major domains of aging under a single overarching concept.
  From here the question arises how "successful aging" itself can be implemented as
  an endpoint in clinical research in a way that it is compliant to methodological
  regulatory framework and recommendations as formulated, for example, by the FDA.
  This article discusses from an applied perspective approaches and examples of how
  ...'
disable_comments: true
---
BACKGROUND AND OBJECTIVES: "Successful aging" as defined in Rowe & Kahn's model aims to include the major domains of aging under a single overarching concept. From here the question arises how "successful aging" itself can be implemented as an endpoint in clinical research in a way that it is compliant to methodological regulatory framework and recommendations as formulated, for example, by the FDA. This article discusses from an applied perspective approaches and examples of how ...